Home - Products - Others - Other Targets - 4-O-Methyllucenin II (Diosmetin 6,8-di-C-glucoside)

4-O-Methyllucenin II (Diosmetin 6,8-di-C-glucoside)

CAS No. 98813-28-6

4-O-Methyllucenin II (Diosmetin 6,8-di-C-glucoside)( —— )

Catalog No. M32284 CAS No. 98813-28-6

Diosmetin 6,8-di-C-glucoside has antioxidant and anti-aging activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-O-Methyllucenin II (Diosmetin 6,8-di-C-glucoside)
  • Note
    Research use only, not for human use.
  • Brief Description
    Diosmetin 6,8-di-C-glucoside has antioxidant and anti-aging activities.
  • Description
    Diosmetin 6,8-di-C-glucoside has antioxidant and anti-aging activities.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    98813-28-6
  • Formula Weight
    624.6
  • Molecular Formula
    C28H32O16
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Biosci Biotechnol Biochem. 2007 Aug;71(8):1911-1199.
molnova catalog
related products
  • Hederasaponin B

    Hederasaponin B has antiviral activity, via inhibiting the viral VP2 protein expression and blocking viral capsid protein synthesis.

  • Lathyrol

    Lathyrol diterpenes is a modulator of P-glycoprotein dependent multidrug resistance.

  • RH01386

    RH01386 is a small molecule that can prevent ER stress-induced β cell dysfunction and death, and inhibits proapoptotic gene expression,has the potential for type 2 diabetes treatment. RH01386 restores ER stress-impaired glucose-stimulated insulin secretion responses.